{"id":"W4386439109","doi":"10.1002/art.42695","title":"<scp>Long‐Term</scp> Efficacy and Safety of Canakinumab in Patients With Tumor Necrosis Factor Receptor–Associated Periodic Syndrome: Results From a Phase <scp>III</scp> Trial","year":2023,"lang":"en","type":"article","venue":"Arthritis & Rheumatology","topic":"Inflammasome and immune disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Canakinumab; Medicine; Tolerability; Adverse effect; Internal medicine; Population; Gastroenterology; Tumor necrosis factor alpha; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001340108,0.0004988263,0.0008263313,0.0001076353,0.0003170188,0.000430481,0.0003722605,0.0004345939,0.001494931],"category_scores_gemma":[0.0006881561,0.0001332179,0.0007828712,0.0002060278,0.0004045245,0.0003198634,0.0002360575,0.001279821,0.000284365],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005728282,"about_ca_system_score_gemma":0.001084166,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001153422,"about_ca_topic_score_gemma":0.002778547,"domain_scores_codex":[0.9997219,0.0001190439,0.00002350687,0.00004056702,0.00003706778,0.00005790185],"domain_scores_gemma":[0.9991974,0.0001264417,0.0002341951,0.00009187461,0.00008451722,0.0002654988],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7507068,0.01611117,0.02199766,0.001367155,0.002119134,0.000242693,0.0002252828,0.002415669,0.04895771,0.0001439718,0.005218058,0.1504948],"study_design_scores_gemma":[0.533132,0.3567008,0.09242287,0.0001129922,0.001232438,0.0006467697,0.00007271471,0.001638149,0.01018767,0.0001537236,0.003658436,0.00004144914],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9970527,0.001035727,0.0001311577,0.0001411284,0.0000256977,0.0005007565,0.0003298453,0.00002394951,0.0007589969],"genre_scores_gemma":[0.9963571,0.0005503914,0.000585182,0.0002417738,0.00008452851,0.0004626787,0.001167994,0.000009296847,0.000541057],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001494931,"threshold_uncertainty_score":0.007087231,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.005634335953272642,"score_gpt":0.2190861418223818,"score_spread":0.2134518058691091,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}